HOB Biotech Group Corp Ltd

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

0.37

Vol. 1Y

—

Shs. 5Y

6.05%

Rev. 5Y

12.42%

Div Yld LY

—

Div Yld TTM

—

Revenues

398m

-0.98%

Net income

23m

-36.96%

CFO

73m

-27.94%

Dividend

May 29, 20260.2 /sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

HOB Biotech Group Corp.,Ltd. is an international in vitro diagnostics firm, active in both China and various global markets. It supplies advanced diagnostic assays, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immunoassays, to laboratories and hospitals. This endeavor aims to improve the treatment and care for patients afflicted with allergies and autoimmune diseases. The company was established in 2009 and is headquartered in Suzhou, China.

URL

http://www.hob-biotech.com/

IPO date

Jan 13, 2021

Employees

Domiciled in

Incorporated in

Valuation

Latest on right Latest on left

Title in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT